Resources
Blog
Resources
Library

For drug manufacturers: Prevent revenue leakage from noncompliant discounts

For drug manufacturers: Prevent revenue leakage from noncompliant discounts

Despite stakeholders' best efforts to conduct compliant and effective Drug Discount Management, noncompliant discounts cost manufacturers more than $8.5 billion dollars annually. Revenue leakage, or revenue that is lost through noncompliant drug discount payments, has expanded over the years and can have a direct impact on the manufacturers’ bottom line. Learn more about how Kalderos’ technology-forward, data-driven approach can help restore compliance, control and bottom-line results.

<span class="blog-button">Download guide</span>

By submitting this form, I agree that Kalderos may contact me at the email address above to tell me about its services. See our Privacy Policy for more details or to opt-out at any time.
Thank you! Your submission has been received.
We will get back to you shortly.
Oops! Something went wrong while submitting the form.
Article published
January 25, 2021